The group’s principal activities include anesthesia and analgesia, real-time image guidance, and conscious sedation. The group’s products include halothane, enflurane, isoflurane, sevoflurane and desflurane.The group marketed its products under the trade names SabreSource (TM) and
Light Sabre (TM). The group operates from the United States. Of the total revenue in the year 2006 The United States accounted for $7,061,831 and international $9,278,833.
